VEXT Science Inc. (C:VEXT)
Business Focus: Medical Farming
You may also be interested in
Insider Filings
Latest 10 SEDI filings for VEXT within the last 6 months
See all filings within the past 6 months
Read full article
Read full article
See more news stories
See all valuations
See Short Report
Loading...
Company News
Apr 24, 2024 18:55 ET
Vext Announces Delay of Annual Filings and Postponement of Conference Call
Vancouver, British Columbia--(Newsfile Corp. - April 24, 2024) - Vext Science, Inc. (CSE: VEXT) (OTCQX: VEXTF) ("Vext" or the "Company"), a U.S.-based cannabis operator with vertical operations in Arizona and Ohio, announces that its annual financial statements for the year ended December 31, 2023, the related management's discussion and analysis and officer certifications (collectively, the "Annual Filings") are not expected to be filed by April 25, 2024, as originally anticipated, or by the required filing deadline of April 29, 2024 (the "Filing Deadline"). As a result of the expected delay in filing the Annual Filings, the Company's previously announced conference call and webcast originally scheduled for April 25, 2024, at 8:00 a.m. ET (the "Conference Call") is postponed until the Annual Filings are completed.
Apr 15, 2024 07:30 ET
Vext to Announce Financial Results for Q4 and Fiscal 2023 on April 25, 2024
Vancouver, British Columbia--(Newsfile Corp. - April 15, 2024) - Vext Science, Inc. (CSE: VEXT) (OTCQX: VEXTF) ("Vext" or the "Company"), a U.S.-based cannabis operator with vertical operations in Arizona and Ohio, today announced that it plans to release its financial results for the period ended December 31, 2023, before market open on April 25, 2024.
Valuation Ratios
Industry
Sector
Beta
1.80
--
--
Price to Sales - TTM
0.76
3.36
3.83
Price to Book - most recent quarter
0.37
1.52
2.18
Price to Cash Flow per share - TTM
2.02
12.07
10.58
Price to Free Cash Flow per share - TTM
6.80
5.91
13.36
Short Report
| Date | Number of Shares Shorted | Net Change |
|---|---|---|
| Apr 15, 2024 | 888 | -5,146 |
| Mar 31, 2024 | 6,034 | -25,156 |
| Mar 15, 2024 | 31,190 | 9,473 |
Business Summary
| Sector: Healthcare | Industry: Healthcare Facilities & Services |
Vext Science, Inc. is a cannabis operator. The Company's expertise spans from cultivation through to retail operations in markets of Arizona and Ohio. It manufactures THC cartridges, concentrates, edibles and accessories under the Vapen brand, and hemp-based products under the Pure Touch Botanicals brand as well as the Vapen CBD and Herbal Wellness brands. It has THC concentrates, edibles, and distillate cartridge brands sold in various states dispensaries. It owns and operates cultivation facilities, fully built-out manufacturing facilities as well as dispensaries in both Arizona and Ohio. Additionally, it provides management, advisory, cultivation, and dispensary services to entities in the cannabis field through joint operations agreements. It also sells CBD products and branded merchandise. Vapen Brands product is the wholesale product and sold in its dispensaries. Vapen Brand is an edible and concentrate brand. The Company also owns cannabis dispensary in Columbus, Ohio.
See business summary
Disclaimer :: Use of this site is subject to, and your continued use
constitutes your express agreement to be bound by, our Legal and Terms of Use. Any commercial use of this site is
strictly prohibited. Canadianinsider.com is operated by INK Research Corp (INK). INK provides general information.
INK has made all reasonable efforts to ensure that all information provided is accurate at the time of inclusion;
however, there may be errors. INK makes no guarantee of accuracy or completeness. All information and opinion
expressed herein is subject to change without notice. Read more...Insider information is based on filings made on the System
for Electronic Disclosure for Insiders (SEDI®). Data is provided “as is” and by using this site
you acknowledge that the information which comprises the data is filed by or on behalf of the SEDI filers or other
parties legally required or permitted to do so. Filings may at any time contain errors and by using this site you
acknowledge this fact. INK is not an investment advisory service, a financial planner, an investment advisor nor a
securities advisor. INK does not purport to tell people, or suggest to people, what they should buy or sell for
themselves. Opinions and recommendations contained herein should not be construed as investment advice. Do not
assume that any recommendations, insights, charts, theories, or philosophies will ensure profitable investment.
Users should always consult with and obtain advice from their professional licensed financial advisor, including
their tax advisor, to determine the suitability of any investment. INK recommends that anyone making an investment
or trading securities do so with caution. Users should perform full due diligence and investigate any security
fully before making an investment or before the execution of a security trade based upon information learned
through INK. Investors should obtain annual reports and other company information to complete their own due
diligence in any investment. Neither INK nor anyone affiliated with INK is responsible for any investment decision
made. INK employees may have an ownership or investment interest in any stock mentioned in this service or on this
website. On this site, there may be third party content, content from authors or links to third-party sites or
pages, the contents of which are not verified, maintained, controlled or supervised by INK. INK is not responsible
for and assumes no liability for the accuracy, completeness or timeliness of any third party content or authored
content provided herein or the information or contents of any linked sites or pages. The inclusion of any authored
content or link by us does not imply that INK recommends, approves or endorses the authored content or linked site
or pages. INK Edge® and INK Research® are registered trade-marks owned by INK Research Corp. SEDI®
is a registered trade-mark owned by the Alberta Securities Commission.Read less
Please make the indicated changes including the new text: US quotes snapshot data provided by IEX. Additional price data and company information powered by Twelve Data.
Interactive technical study charts by TradingView. Copyright © 2024 INK Research Corp. All rights reserved. All trade-marks or trade names not owned by INK Research Corp. are the property of their respective owners.
